Clinical Trial Update: Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma [NA]

View source ↗

Summary

A completed clinical trial update examining whether dysregulated glutamine metabolism contributes to the pathogenesis of multiple myeloma. The study appears to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma

Snippet

Sponsor: Mayo Clinic | Conditions: Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Myeloma | NA | Status: COMPLETED